LivaNova PLC Accounts Receivable, Allowance for Credit Loss, Current
LivaNova PLC (LIVN) had Accounts Receivable, Allowance for Credit Loss, Current of $10.72 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $10.72M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $10.31M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $12.53M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $13.31M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.72M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $10.31M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $12.53M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $13.31M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $12.86M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $11.48M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $11.28M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $12.13M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $10.90M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $11.03M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $12.02M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $11.63M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $11.61M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $11.49M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $11.86M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $11.35M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $13.11M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $13.49M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $13.51M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $11.84M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $12.00M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $11.27M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $10.31M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $16.24M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $15.32M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $14.15M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $13.11M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $12.25M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $11.89M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $11.48M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $11.60M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $9.46M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $9.56M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $6.49M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $9.42M 10-K · filed 2019-03-18 | $5.98M 10-K · filed 2018-02-28 |
| 2017-09-30 | $12.46M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $11.51M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $10.54M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $3.74M 10-K · filed 2018-02-28 | $9.61M 10-K · filed 2017-03-01 |
| 2016-09-30 | $7.28M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $7.31M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.89M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.65M 10-K · filed 2017-03-01 | |
| 2015-10-18 | $876.58K 10-Q · filed 2015-12-08 | |
| 2015-04-24 | $664.00K 10-K · filed 2017-03-01 | $664.20K 10-Q · filed 2015-12-02 |
| 2014-04-25 | $685.00K 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |